Genome-Wide Analysis Studies and Chronic Kidney Disease

Area of Science:

• Nephrology
• Genetics
• Epidemiology

Background:

• Chronic kidney disease (CKD) is a global health concern with increasing prevalence, often described as an epidemic.
• CKD progression is highly variable among patients, even with controlled risk factors like blood pressure and glucose levels.
• Genetic factors are increasingly recognized as playing a significant role in CKD development and progression.

Purpose of the Study:

• To review the impact and findings of genome-wide association studies (GWAS) in understanding the genetic underpinnings of chronic kidney disease (CKD).
• To explore how genetic discoveries can illuminate CKD-related biological pathways.
• To discuss the potential of genetic insights for advancing CKD diagnosis, prevention, and treatment.

Main Methods:

• This review synthesizes findings from genome-wide association studies (GWAS) published over the last decade.
• The analysis focuses on genetic loci identified in association with chronic kidney disease (CKD).
• The review examines the contribution of GWAS to understanding CKD etiology and pathogenesis.

Main Results:

• Over the past decade, GWAS have successfully identified more than 50 distinct genetic loci associated with chronic kidney disease (CKD).
• These genetic associations provide valuable clues into the biological pathways implicated in CKD.
• The identified loci highlight the complex genetic architecture contributing to CKD risk and progression.

Conclusions:

• Genome-wide association studies (GWAS) are powerful tools for dissecting the genetic basis of chronic kidney disease (CKD).
• Understanding the genetic landscape of CKD can enhance our knowledge of disease mechanisms.
• Genetic discoveries hold promise for developing novel diagnostic markers and therapeutic targets for CKD.